2023
Use, Durability, and Risks for Discontinuation of Initial and Subsequent Biologics in a Large Pediatric‐Onset IBD Cohort
Kaplan J, Liu C, King E, Bass J, Patel A, Tung J, Chen S, Lissoos T, Candela N, Saeed S, Colletti R, Network I, Adler J, Baron H, Cabrera J, Dorsey J, Dykes D, Ebach D, Garin‐Laflam M, Gold B, Grunow J, Higuchi L, Jester T, Lapsia S, Leibowitz I, Linvlle T, Morhardt T, Moses J, Moulton D, Nasiri‐Blomgren S, Niklinska‐Schirtz B, Ogunmola N, Palomo P, Park K, Pashankar D, Pasternak B, Radano M, Samson C, Sandberg K, Schaefer M, Shashidhar H, Steiner S, Sullivan J, Tomer G, Verstraete S. Use, Durability, and Risks for Discontinuation of Initial and Subsequent Biologics in a Large Pediatric‐Onset IBD Cohort. Journal Of Pediatric Gastroenterology And Nutrition 2023, 76: 566-575. PMID: 36804501, PMCID: PMC10097486, DOI: 10.1097/mpg.0000000000003734.Peer-Reviewed Original ResearchMeSH KeywordsAdalimumabAdolescentBiological FactorsBiological ProductsChildColitis, UlcerativeCrohn DiseaseHumansInflammatory Bowel DiseasesInfliximabConceptsCrohn's diseaseUlcerative colitisLoss of responseFirst biologicSubsequent biologicsBiologic agentsBiologic medicationsBiologic treatmentAnti-tumor necrosis factor agentsUpper gastrointestinal tract involvementGastrointestinal tract involvementNecrosis factor agentsActive Crohn's diseaseFirst biologic agentIBD cohortInitial biologicSecond biologicTract involvementCorticosteroid useFactor agentsPediatric IBDBiologic initiationDisease courseUnivariate analysisSevere disease
2018
Seroimmunity to Hepatitis B Virus in Children With Inflammatory Bowel Disease
Phatak U, Rojas‐Velasquez D, Pashankar DS. Seroimmunity to Hepatitis B Virus in Children With Inflammatory Bowel Disease. Journal Of Pediatric Gastroenterology And Nutrition 2018, 66: e137-e137. PMID: 29287017, DOI: 10.1097/mpg.0000000000001885.Peer-Reviewed Original ResearchChildHepatitis B AntibodiesHepatitis B virusHumansImmunization, SecondaryIncidenceInflammatory Bowel DiseasesVaccination
2017
Prevalence and Patterns of Marijuana Use in Young Adults With Inflammatory Bowel Disease
Phatak UP, Rojas‐Velasquez D, Porto A, Pashankar DS. Prevalence and Patterns of Marijuana Use in Young Adults With Inflammatory Bowel Disease. Journal Of Pediatric Gastroenterology And Nutrition 2017, 64: 261-264. PMID: 27846066, DOI: 10.1097/mpg.0000000000001474.Peer-Reviewed Original ResearchConceptsInflammatory bowel diseaseBowel diseaseYoung adultsAdverse effectsMarijuana useNeuropsychiatric adverse effectsPediatric IBD clinicsHalf of patientsPossible adverse effectsIBD clinicIBD therapyAbdominal painDisease activityIBD symptomsPoor appetiteMedical therapySymptom reliefComplete reliefSymptom improvementPatientsNonusers of marijuanaUse of marijuanaAnonymous questionnaireMedical marijuanaLegalization of marijuana
2015
Obesity and Gastrointestinal Disorders in Children
Phatak UP, Pashankar DS. Obesity and Gastrointestinal Disorders in Children. Journal Of Pediatric Gastroenterology And Nutrition 2015, 60: 441-445. PMID: 25493349, DOI: 10.1097/mpg.0000000000000670.Peer-Reviewed Original ResearchMeSH KeywordsCeliac DiseaseChildGastrointestinal DiseasesHumansInflammatory Bowel DiseasesIrritable Bowel SyndromePediatric ObesityConceptsGastrointestinal disordersCommon GI disordersOrganic GI diseaseAssociation of obesityFunctional gastrointestinal disordersInflammatory bowel diseaseGI disordersBowel diseaseObese childrenGI diseaseCeliac diseasePossible complicationsComprehensive careClinical significanceObesityDiseaseDisordersChildrenGlobal pandemicAssociationPresent dataRecent studiesPossible mechanismComplicationsPhysicians